Alla Patlis - 01 Jan 2025 Form 4 Insider Report for BRAINSTORM CELL THERAPEUTICS INC. (BCLI)

Role
Interim Chief Financial Officer & Controller
Signature
/s/ Alla Patlis
Issuer symbol
BCLI
Transactions as of
01 Jan 2025
Net transactions value
$0
Form type
4
Filing time
03 Jan 2025, 17:33:21 UTC
Previous filing
13 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCLI Common Stock Award $0 +40,000 +920% $0.000000 44,349 01 Jan 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of restricted stock awarded under the Issuer's 2014 Global Share Option Plan. The shares of restricted stock shall vest as to (i) 50% of the award on the six-month anniversary of the date of grant and (ii) the remaining 50% of the award shall vest on the eighteenth-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date.
F2 Reflects the Issuer's 1-for-15 reverse stock split effected market open on October 1, 2024.

Remarks:

Interim Chief Financial Officer & Controller